Cargando…

Sotatercept Safety and Effects on Hemoglobin, Bone, and Vascular Calcification

INTRODUCTION: Patients with end-stage kidney disease (ESKD) exhibit anemia, chronic kidney disease‒mineral bone disorder (CKD–MBD), and cardiovascular disease. The REN-001 and REN-002 phase II, multicenter, randomized studies examined safety, tolerability, and effects of sotatercept, an ActRIIA-IgG1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coyne, Daniel W., Singh, Hem N., Smith, William T., Giuseppi, Ana Carolina, Connarn, Jamie N., Sherman, Matthew L., Dellanna, Frank, Malluche, Hartmut H., Hruska, Keith A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933454/ https://www.ncbi.nlm.nih.gov/pubmed/31891000 http://dx.doi.org/10.1016/j.ekir.2019.08.001

Ejemplares similares

Early chronic kidney disease-mineral bone disorder stimulates vascular calcification
por: Fang, Yifu, et al.
Publicado: (2013)

Sotatercept in patients with osteolytic lesions of multiple myeloma
por: Abdulkadyrov, Kudrat M, et al.
Publicado: (2014)

Higher mineralized bone volume is associated with a lower plain X-Ray vascular calcification score in hemodialysis patients
por: Adragao, Teresa, et al.
Publicado: (2017)

Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension
por: Joshi, Sachindra R., et al.
Publicado: (2022)

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
por: Humbert, Marc, et al.
Publicado: (2023)

Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trial
por: Souza, Rogerio, et al.
Publicado: (2023)

Low Turnover Renal Osteodystrophy With Abnormal Bone Quality and Vascular Calcification in Patients With Mild-to-Moderate CKD
por: El-Husseini, Amr, et al.
Publicado: (2022)

Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure
por: Joshi, Sachindra R., et al.
Publicado: (2023)

Sotatercept for the treatment of pulmonary arterial hypertension: a meta-analysis of randomized controlled trials
por: Jaiswal, Vikash, et al.
Publicado: (2023)

Effects of Sucroferric Oxyhydroxide Compared to Lanthanum Carbonate and Sevelamer Carbonate on Phosphate Homeostasis and Vascular Calcifications in a Rat Model of Chronic Kidney Failure
por: Phan, Olivier, et al.
Publicado: (2015)

Idiopathic pulmonary fibrosis: Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
por: Hadi, Dalia D., et al.
Publicado: (2023)

Testing Vitamin D Analogues for Vascular Calcification in Patients With CKD
por: Ramakrishnan, Madhuri, et al.
Publicado: (2020)

Overview on hydrogen sulfide-mediated suppression of vascular calcification and hemoglobin/heme-mediated vascular damage in atherosclerosis
por: Gáll, Tamás, et al.
Publicado: (2022)

Vascular Calcification and Renal Bone Disorders
por: Lu, Kuo-Cheng, et al.
Publicado: (2014)

Coronary artery calcification in CKD-5D patients is tied to adverse cardiac function and increased mortality
por: Anaya, Paul, et al.
Publicado: (2016)

Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone–Vascular Axis
por: De Maré, Annelies, et al.
Publicado: (2019)

Prevalence of low bone formation in untreated patients with osteoporosis
por: Malluche, Hartmut H., et al.
Publicado: (2022)

Gender Difference in Bone Loss and Vascular Calcification Associated with Age
por: Lee, Dong-Hyeon, et al.
Publicado: (2013)

Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?
por: Cannata-Andía, Jorge B., et al.
Publicado: (2021)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based chemotherapeutic regimens: results from two phase 2 studies
por: Raftopoulos, Haralambos, et al.
Publicado: (2015)

Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification
por: Gravesen, Eva, et al.
Publicado: (2018)

The Dual Role of Vitamin K2 in “Bone-Vascular Crosstalk”: Opposite Effects on Bone Loss and Vascular Calcification
por: Mandatori, Domitilla, et al.
Publicado: (2021)

The Enigma of Vascular Calcifications
por: Sprague, Stuart M.
Publicado: (2020)

Osteoporosis and vascular calcifications
por: Martini, Nancy, et al.
Publicado: (2023)

Role of Bisphosphonates in Vascular Calcification and Bone Metabolism: A Clinical Summary
por: Dayanand, Pradeep, et al.
Publicado: (2018)

The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
por: Yu, Chenyang, et al.
Publicado: (2020)

Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
por: Mace, Maria L, et al.
Publicado: (2020)

Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study
por: Cappellini, Maria Domenica, et al.
Publicado: (2019)

Response to “Low Turnover Bone Disease in Early CKD Stages”
por: El-Husseini, Amr, et al.
Publicado: (2022)

Diagnosis of low bone mass in CKD-5D patients
por: Blomquist, Gustav A., et al.
Publicado: (2016)

Quantitative analysis of vascular calcification
por: JOH, JIN HYUN, et al.
Publicado: (2014)

The Role of Mitochondria in Vascular Calcification
por: Wang, Pengbo, et al.
Publicado: (2020)

Wnt Signaling in Vascular Calcification
por: Bundy, Kaylee, et al.
Publicado: (2021)

Role of Glycosylation in Vascular Calcification
por: Masbuchin, Ainun Nizar, et al.
Publicado: (2021)

Shifting osteogenesis in vascular calcification
por: Yao, Jiayi, et al.
Publicado: (2021)

The Thermodynamics of Medial Vascular Calcification
por: Millán, Ángel, et al.
Publicado: (2021)

Contributions of the Endothelium to Vascular Calcification
por: Zhang, Li, et al.
Publicado: (2021)

Alendronate as an Effective Treatment for Bone Loss and Vascular Calcification in Kidney Transplant Recipients
por: Okamoto, Masanori, et al.
Publicado: (2014)

Osteoprotegerin, Pericytes and Bone-Like Vascular Calcification Are Associated with Carotid Plaque Stability
por: Davaine, Jean-Michel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0idevk445dtngsnrpukok59gdq